NCT07457229

Radiprodil in Participants With Hepatic Impairment

RecruitingPHASE1INTERVENTIONAL

Trial Details

Start: 2026-03-03Est. Completion: 2027-05

Enrollment target: 40 participants

Locations

Contact

Aneeta Saxena

Ganglioneuroblastoma, NodularNeuroblastoma

This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care su…

Birmingham, United StatesEst. completion Dec 31, 2029

Healthy VolunteersHepatic Impairment

The purpose of this study is to determine the pharmacokinetic and safety of BMS-986435 in participants with normal hepat…

Chandler, United StatesEst. completion Aug 5, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.